EGFR and esophageal cancer: Overexpression of YAP is associated with chemoresistance in esophageal cancer, and its interaction with the TEAD binding site in the EGFR promoter resulted in increased EGFR expression at the transcriptional level, causing resistance to 5-Fu and docetaxel [32].